Tune into this webinar to learn about the UK ATMP landscape in 2021
Watch the Webinar
Please provide your details to gain access.
The Cell and Gene Therapy Catapult takes your data very seriously. By using this form you are consenting to the processing of your personal data as per ourprivacy policy.
Event Description
The UK holds a leading position in the global Advanced Therapy Medicinal Product (ATMP) industry. Hear how the Cell and Gene Therapy Catapult (CGT Catapult) is working collaboratively with key stakeholders from academia, industry, the NHS and Government to facilitate the growth of the UK ecosystem for widespread delivery of these innovative treatments to patients.
This presentation is taken from the Alliance for Regenerative Medicine (ARM) and CGT Catapult UK Stakeholder meeting held on 12th March 2021.